# Cephalon

> Cephalon is a VC fund in Malvern backing Therapeutics and Biotechnology. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Malvern, United States
- Total investments: 1
- Last investment: Dec 2009
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/teva-pharmaceutical-industries-l
- Website: http://www.cephalon.com

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction ofbeing one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries.

## Contacts

5 contacts available for Cephalon. Shizune tracks 2 team members at Cephalon. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cephalon?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Frank Baldino, Jr. | Chairman & CEO | 0 | — |
| Piyush Patel | Director | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SymBio Pharmaceuticals | SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan. | $311.8M |  | Dec 11, 2009 |  |

1 of 1 investments shown.

## Co-investors
- [Daiwa Corporate Investment](https://shizune.co/investors/profile/daiwa-corporate-investment) — VC Fund, 1 deal together
- [Eisai](https://shizune.co/investors/profile/eisai-co) — VC Fund, 1 deal together
- [Shinkin Capital](https://shizune.co/investors/profile/shinkin-capital) — VC Fund, 1 deal together
- Toyo Securities — VC Fund, 1 deal together
- [Waseda University](https://shizune.co/investors/profile/waseda-university) — VC Fund, 1 deal together
- [WERU Investment](https://shizune.co/investors/profile/weru-investment) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Cephalon invest in?

Cephalon invests primarily in Therapeutics, Biotechnology and Pharmaceutical startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cephalon?

Public channels for Cephalon include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cephalon?

The team at Cephalon includes Frank Baldino, Jr. (Chairman & CEO) and Piyush Patel (Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co